Brenda Arnett - Concepedia

Author

Brenda Arnett

Also Known As

Brenda Arnett

Publications

422

Citations

H-Index

Concepts

All Affiliations

Brenda Arnett is an author at Texas Oncology specializing in medicine, drug discovery, and molecular recognition.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	65
2	Natural Sciences	1	1	11
3	Biochemistry	1	1	54
4	Molecular Biology	1	1	11
5	Pharmacology	1	1	54

Brenda Arnett

Publications

422

Citations

H-Index

Page 1

	Year	Citations
Oxaliplatin-Induced Damage of Cellular DNA Jan M. Woynarowski, Sandrine Faivre, Maryanne C. Herzig, Molecular Pharmacology	2000	298
Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF) Maryanne C. Herzig, Brenda Arnett, John R. MacDonald, Biochemical Pharmacology Pharmaceutical ScienceBiochemistryMedicineCellular PharmacologyDrug Uptake	1999	54
Region-Specific DNA Damage by AT-Specific DNA-Reactive Drugs Is Predicted by Drug Binding Specificity<sup>,</sup> Jan M. Woynarowski, Cheryl Napier, Alex V. Trevino, Biochemistry	2000	19
Tallimustine Lesions in Cellular DNA are AT Sequence-Specific but Not Region-Specific Maryanne C. Herzig, Alex V. Trevino, Brenda Arnett, Biochemistry	1999	14
Expression of CAAT enhancer binding protein beta (C/EBP beta) in cervix and endometrium. Brenda Arnett, Patrick Soisson, Barbara S. Ducatman, Molecular Cancer	2003	14
Oxaliplatin-Induced Damage of Cellular DNA Jan M. Woynarowski, Sandrine Faivre, Maryanne C. Herzig, Molecular Pharmacology	2000	12
The Genome Factor in Region-Specific DNA Damage: The DNA-Reactive Drug U-78779 Prefers Mixed A/T-G/C Sequences at the Nucleotide Level but Is Region-Specific for Long Pure AT Islands at the Genomic Level Maryanne C. Herzig, Karl A. Rodriguez, Alex V. Trevino, Biochemistry Drug TargetDna DamageRegion-specific Dna DamageGeneticsDna Analysis	2002	11

Page 1